1029 related articles for article (PubMed ID: 22034086)
1. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
[TBL] [Abstract][Full Text] [Related]
2. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
[TBL] [Abstract][Full Text] [Related]
3. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
[TBL] [Abstract][Full Text] [Related]
4. Potential of MR mammography to predict tumor grading of invasive breast cancer.
Dietzel M; Baltzer PA; Vag T; Zoubi R; Gröschel T; Burmeister H; Gajda M; Runnebaum IB; Kaiser WA
Rofo; 2011 Sep; 183(9):826-33. PubMed ID: 21442559
[TBL] [Abstract][Full Text] [Related]
5. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
6. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast].
Wersebe A; Xydeas T; Clauss T; Dietz K; Belka C; Fersis N; Claussen CD; Müller-Schimpfle M
Rofo; 2001 Dec; 173(12):1109-17. PubMed ID: 11740672
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
9. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
10. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E
Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
13. [MR imaging of the breast before and after neoadjuvant treatment - enhancement characteristics and T 2 signal intensity of breast cancers and breast parenchyma].
Siegmann KC; Müller KT; Vogel U; Krauss K; Claussen CD
Rofo; 2010 Jun; 182(6):493-500. PubMed ID: 19953430
[TBL] [Abstract][Full Text] [Related]
14. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI.
Gibbs P; Liney GP; Lowry M; Kneeshaw PJ; Turnbull LW
Breast; 2004 Apr; 13(2):115-21. PubMed ID: 15019691
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance findings in women at high risk for developing breast cancer: an Australian feasibility study.
Peters G; Anderson J; Longman G; Thomson J; Taylor D; Bennett M; Wylie E; Goldblatt J; Chan A; Saunders C
J Med Imaging Radiat Oncol; 2008 Feb; 52(1):29-35. PubMed ID: 18373823
[TBL] [Abstract][Full Text] [Related]
17. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
19. T1-weighted 3D dynamic contrast-enhanced MRI of the breast using a dual-echo Dixon technique at 3 T.
Dogan BE; Ma J; Hwang K; Liu P; Yang WT
J Magn Reson Imaging; 2011 Oct; 34(4):842-51. PubMed ID: 21769987
[TBL] [Abstract][Full Text] [Related]
20. The role of STIR MRI sequence in the evaluation of the breast following conservative surgery and radiotherapy.
Forrai G; Polgar C; Zana K; Riedl E; Fodor J; Nemeth G; Fornet B
Neoplasma; 2001; 48(1):7-11. PubMed ID: 11327541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
